Timothy Springer

Timothy Springer

Timothy Springer (#3389)

  • $ 1 B
  • Biotech
  • United States
  • M
  • 78 Years

About Me

Timothy Springer is an immunologist and professor of biological chemistry and molecular pharmacology at Harvard Medical School. He was a founding investor in publicly traded biotech outfit Moderna, investing about $5 million in 2010; he now owns an estimated 3% of the firm's shares. Springer also owns shares of three smaller publicly traded biotech firms: Cartesian Therapeutics, Scholar Rock and Tectonic Therapeutic. He first started teaching at Harvard in 1977 as an assistant professor. In 1993, he founded biotech firm LeukoSite and took it public in 1998; the next year, he sold it to Millennium Therapeutics for $635 million.
About Images

Achievements

Career Highlights

A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Timothy Springer’s rise and global influence.

  • #3185   Billionaires (2026)
  • #176   Forbes 400 (2021)

Wealth Growth

Net Worth Growth Over Time

Tracking Timothy Springer’s net worth journey over the years, highlighting key growth phases and financial milestones.

Current Net Worth: $1.0B (May 5, 2026)